These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 4871210)

  • 1. Sustained-action phendimetrazine in obesity.
    Hadler AJ
    J Clin Pharmacol J New Drugs; 1968; 8(2):113-7. PubMed ID: 4871210
    [No Abstract]   [Full Text] [Related]  

  • 2. Mazindol, a new non-amphetamine anorexigenic agent.
    Hadler AJ
    J Clin Pharmacol New Drugs; 1972; 12(11):453-8. PubMed ID: 4563662
    [No Abstract]   [Full Text] [Related]  

  • 3. Availability of phendimetrazine from sustained and non-sustained action formulations.
    Müller FO; Hundt HK; Gosling JA
    S Afr Med J; 1975 Feb; 49(5):135-9. PubMed ID: 1173199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anorexigenic activity of intermittent dextroamphetamine with and without meprobamate.
    Noble RE
    Curr Ther Res Clin Exp; 1972 Apr; 14(4):162-7. PubMed ID: 4623595
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical evaluation of the activity oof 2 new anorectics].
    Rinetti M; Barbaresi F; Colombi L
    Schweiz Rundsch Med Prax; 1970 Apr; 59(17):633-7. PubMed ID: 4928198
    [No Abstract]   [Full Text] [Related]  

  • 6. Oberex, a new appetite-reducing agent.
    Bjurulf P; Carlström S; Rorsman G
    Acta Med Scand; 1967 Sep; 182(3):273-80. PubMed ID: 4862332
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of phentermine-amphetamine resin complex with sustained-release dextroamphetamine and placebo in the treatment of exogenous obesity.
    De Felice EA; Cohen A; Schmitz PL; Rothwell KG; Truant AP
    J Clin Pharmacol J New Drugs; 1968; 8(6):360-9. PubMed ID: 4883784
    [No Abstract]   [Full Text] [Related]  

  • 8. Body weight changes in overweight patients following an appetite suppressant in a controlled environment.
    Sandoval RG; Wang RI; Rimm AA
    J Clin Pharmacol New Drugs; 1971; 11(2):120-4. PubMed ID: 4929289
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical long-term testing of a new appetite depressant Ro 4-5282 (Pondinil)].
    Jenny S; Rhomberg F
    Schweiz Rundsch Med Prax; 1970 Jul; 59(28):1042-4. PubMed ID: 4934638
    [No Abstract]   [Full Text] [Related]  

  • 10. [Phendimetrazine--a new central stimulant on the narcotic market].
    Axelsson S; Jönsson S; Sjöstedt L; Tunving K
    Lakartidningen; 1974 Jun; 71(23):2385-7. PubMed ID: 4407301
    [No Abstract]   [Full Text] [Related]  

  • 11. [Therapeutic trial of an anorectic agent using the double blind cross-over technic].
    Bienert HR; Uberla K
    Arzneimittelforschung; 1967 Mar; 17(3):336-42. PubMed ID: 4869817
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical evaluation of the anorexic activity and safety of 42-548 in children. Report of a clinical trial.
    Sharma RK; Collipp PJ; Rezvani I; Strimas J; Maddaiah VT; Rezvani E
    Clin Pediatr (Phila); 1973 Mar; 12(3):145-9. PubMed ID: 4573674
    [No Abstract]   [Full Text] [Related]  

  • 13. Hyperinsulinemia secondary to chronic administration of mazindol and d-amphetamine.
    Sirtori C; Hurwitz A; Azarnoff DL
    Am J Med Sci; 1971 Jun; 261(6):341-9. PubMed ID: 4948438
    [No Abstract]   [Full Text] [Related]  

  • 14. Anorectic effectiveness of various dosages of fenfluramine and placebo: a cooperative study.
    Dent RW; Preston LW
    Curr Ther Res Clin Exp; 1975 Jul; 18(1 pt 2):132-43. PubMed ID: 809229
    [No Abstract]   [Full Text] [Related]  

  • 15. Dental considerations of patients taking appetite suppressants.
    Wynn RL
    Gen Dent; 1997; 45(4):324-8, 330-1. PubMed ID: 9515435
    [No Abstract]   [Full Text] [Related]  

  • 16. Central Retinal Vein Occlusion Noted 2 Days After Use of Phendimetrazine as an Appetite Suppressant.
    Cho AR; Yoon YH
    JAMA Ophthalmol; 2016 Apr; 134(4):463-4. PubMed ID: 26846182
    [No Abstract]   [Full Text] [Related]  

  • 17. [On the testing of the central side-effects of appetite depressants].
    Klein K
    Med Klin; 1966 Sep; 61(35):1391-4. PubMed ID: 5998594
    [No Abstract]   [Full Text] [Related]  

  • 18. Dilated cardiomyopathy associated with chronic consumption of phendimetrazine.
    Rostagno C; Caciolli S; Felici M; Gori F; Neri Serneri GG
    Am Heart J; 1996 Feb; 131(2):407-9. PubMed ID: 8579044
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparative pharmacodynamic activity of single and divided doses of benzphetamine hydrochloride.
    Schlagel CA; Sanborn EC
    J Pharm Sci; 1969 Dec; 58(12):1453-6. PubMed ID: 4901011
    [No Abstract]   [Full Text] [Related]  

  • 20. Anorectic effectiveness of differing dosage forms of fenfluramine.
    Tisdale SA; Ervin DK
    Curr Ther Res Clin Exp; 1976 Jun; 19(6):589-94. PubMed ID: 819218
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.